Highest-materiality recent filing
Peraso amends equity purchase agreement; Roth Principal discount set at 5% of VWAP
Roth Principal Investments agrees to 5.0% discount on VWAP for Pre-Market and Post-Market purchases under existing Common Stock Purchase Agreement.
Peraso enters $25M committed equity facility with Roth Principal Investments
Up to $25M of common stock may be sold to Roth Principal Investments at company's discretion.
Peraso ups ATM offering capacity by $670,000; $9.37M already sold
Filed prospectus supplement to increase max shares under ATM with Ladenburg Thalmann to $670,000 aggregate.
Peraso Q1 revenue $1.0M, net loss widens to $2.5M on supply chain delay
Revenue $1.0M vs $3.9M YoY; product revenue $0.7M down from $3.8M.
Peraso delivers initial limited-production 60GHz modules for military IFF to iNTACT
First limited production shipment of proprietary 60GHz modules for IFF applications to iNTACT, an Israeli defense contractor.
Peraso cuts Q1 2026 revenue guidance to $0.9-1.0M from $1.2M; ups ATM by $2.125M
Preliminary Q1 total revenue now $0.9M-$1.0M, down from prior estimate of $1.2M announced March 16.
Peraso reports FY2025 revenue $12.2M, net loss $4.8M; mmWave product revenue up 6x YoY
Full year 2025 total net revenue $12.2M, down from $14.6M in 2024; GAAP net loss $4.8M ($0.67/sh) vs $10.7M loss in 2024.
Peraso awards 60k options each to CEO, CFO, COO at $0.87 strike
CEO Ronald Glibbery, CFO James Sullivan, and COO Bradley Lynch each receive 60,000 stock options.
Peraso and Mobix Labs continue discussions regarding a potential strategic transaction after signing a mutual confidentiality agreement on October 30, 2025.
Peraso appoints wireless pioneer Cees Links to Board; amends stock incentive plan
Cees Links, founder of GreenPeak (acquired by Qorvo), appointed to Board effective after Dec 22 annual meeting; replaces retiring Ian McWalter.
Peraso extends Series C warrant expiration to January 7, 2026
Extension covers 1,293,650 shares at $1.61 exercise price; third amendment since original May 6, 2025 expiry.
Peraso boosts ATM equity offering by $3.15M; director McWalter to retire
Director Ian McWalter will not stand for re-election at 2025 annual meeting; retirement unrelated to company policies.
Peraso Q3 revenue $3.2M (+45% seq); mmWave product revenue hits record $3.1M
GAAP net loss $1.2M ($0.17/shr) vs $1.8M ($0.31/shr) in Q2 2025.
Peraso enters confidentiality agreement with Mobix Labs in strategic review process
Mutual confidentiality agreement with Mobix Labs signed on Oct 30, 2025.
Peraso increases ATM offering capacity by $1.75M; $2.69M already sold
On Oct 10, 2025, Peraso filed a prospectus supplement to increase ATM shares issuable to $1.75M (in addition to $2,686,953 already sold).
Peraso reports 7.58M common shares outstanding; discloses extensive warrant overhang
As of Oct 3, 2025: 7,579,223 common shares outstanding; one Series A preferred share.
Peraso regains Nasdaq minimum bid price compliance; delisting risk removed
Received Nasdaq letter on Sept 19, 2025 confirming compliance with Rule 5550(a)(2).
Peraso secures ~$1.1M via warrant exercise inducement, issues new Series E warrants
Existing Series C warrant holder exercises 952,380 shares at reduced price $1.18 (from $1.61), gross proceeds ~$1.1M.
Peraso receives revised unsolicited proposal from Mobix Labs; agrees to exploratory call
Mobix Labs submitted revised proposal on Sept 4 with cash and stock consideration in undetermined amount.
Peraso receives Nasdaq deficiency notice for minimum bid price non-compliance
Nasdaq letter on Sept 5, 2025: closing bid price below $1 for 30 consecutive business days ended Sept 4, 2025.
Peraso updates strategic review; Mobix Labs declines confidentiality agreement
Board authorized strategic alternatives exploration on July 11, 2025; retained Craig-Hallum Capital Group as financial advisor.
Peraso Q2 revenue $2.2M, mmWave product revenue up 45% sequentially; guides Q3 revenue $2.8-3.1M
GAAP net loss $1.8M ($0.31 per share) vs $4.4M loss ($1.88) in Q2 2024.
Peraso extends Series C warrant expiration to Dec 5, 2025; exercise price $1.61
Extension of Series C warrants covering up to 2,246,030 shares, expiring Dec 5, 2025 (from Aug 4, 2025).
Peraso authorizes strategic alternatives review, retains Craig-Hallum, evaluates Mobix Labs proposal
Board authorized exploration of strategic alternatives including merger or sale of assets.
Peraso Inc. receives unsolicited acquisition proposal from Mobix Labs at ~$1.20/share
Peraso Inc. confirms receipt of unsolicited non-binding acquisition proposal from Mobix Labs, Inc.
Peraso regains Nasdaq minimum bid price compliance
Received Nasdaq letter on June 18, 2025 confirming compliance with Rule 5550(a)(2).
Peraso Q1 revenue up 37% YoY to $3.9M; GAAP net loss narrows to $0.10/sh
Total revenue $3.9M vs $2.8M YoY; mmWave product revenue exceeded full-year 2024 total.
Peraso extends Series C warrant expiration to Aug 4, 2025 for 2.25M shares at $1.61
Warrant extension covers up to 2,246,030 shares with exercise price of $1.61 per share.
Peraso receives Nasdaq deficiency notice for minimum bid price below $1
Received Nasdaq letter on April 4, 2025, due to closing bid price below $1 for 30 consecutive business days ending April 3.
Peraso Q4 revenue $3.7M (+100% YoY); GAAP gross margin 56.3%; net loss narrows to $1.6M
Q4 revenue of $3.7M, up 100% YoY, driven by memory IC end-of-life shipments; GAAP gross margin improved to 56.3% from negative 147.3%.
Peraso grants 100,000 stock options each to CEO, CFO, and COO at $0.7776 strike
100,000 options awarded to CEO Ronald Glibbery, CFO James Sullivan, and COO Bradley Lynch on Feb 11, 2025.
Peraso shareholders approve all four proposals at 2024 annual meeting
All six director nominees elected with between 93.5–95.4% of votes cast (excluding broker non-votes).
Peraso increases ATM offering capacity to up to $2.7 million from prior cap
Filing ups maximum shares for sale under August 2024 ATM agreement to $2,693,527 aggregate gross proceeds.
Peraso regains Nasdaq minimum equity compliance after $2.6M warrant inducement offering
As of Sept 30, 2024, stockholders' equity was ~$2,026,000, below Nasdaq's $2.5M minimum.
Peraso posts Q3 2024 revenue of $3.8M, GAAP net loss $2.7M; guides Q4 at $3.6-$4.0M
Revenue $3.8M, down 16% YoY from $4.5M; product revenue $3.8M.
Peraso raises $2.9M via warrant exercise, issues new Series C and D warrants
Existing Series B warrants exercised at $1.30/sh, reduced from $2.25; gross proceeds ~$2.9M.
Peraso extends Series B warrant expiration from Oct 7 to Nov 8, 2024
Extended expiration of Series B warrants (3,974,520 shares) from Oct 7 to Nov 8, 2024.
Peraso enters into ATM equity offering agreement for up to $1.425M
Aggregate offering price up to $1,425,000 of common stock under ATM with Ladenburg Thalmann.
Peraso Q2 revenue $4.2M (+50.5% seq); GAAP net loss $4.4M
Q2 revenue $4.2M, up 50.5% sequentially and ~75% YoY; GAAP gross margin 55.5% (vs 46.4% prior qtr, 25.3% YoY).
Peraso extends Series B warrant expiration to October 7, 2024
Extended expiration of Series B warrants from Aug 8, 2024 to Oct 7, 2024.
Peraso preliminary Q2 revenue ~$4.2M, above guidance; mmWave DUNE platform order in hand
Preliminary Q2 2024 revenue ~$4.2M, exceeding guidance range of $3.7–$4.0M.
Peraso sells 100,000 shares to director Ian McWalter at $1.27/share for $127K
Director Ian McWalter purchased 100,000 shares at $1.27 per share for $127,000 total.
Peraso Q1 revenue $2.8M (+54% seq), GAAP net loss $2.0M; guides Q2 $3.7-4.0M
Q1 revenue $2.8M, up 54% sequentially from $1.8M; product revenue $2.7M.
Peraso receives additional $2.88M EOL purchase order for memory IC products
Non-cancelable order from a customer; total EOL purchase orders now approximately $16.9M, majority in backlog.
Peraso Q4 revenue $1.8M, GAAP net loss $8.9M; inventory write-down drives negative gross margin
Q4 revenue $1.8M (down 60% from Q3 2023); GAAP net loss $8.9M ($12.48 per share).
Peraso raises $4.2M in underwritten public offering of common stock and warrants
Closed offering of 562,500 shares, pre-funded warrants, Series A (5yr, $2.25) and Series B (6mo, $2.25) warrants.
Peraso estimates Q4 2023 total revenue $1.6M-$1.9M; cash $1.6M
Total revenue for Q4 2023 estimated at $1.6M-$1.9M, with product revenue of $1.5M.
Peraso regains Nasdaq compliance with minimum bid price requirement
Nasdaq notified Peraso on Jan 18, 2024 that it now meets the $1.00 minimum bid price for 10 consecutive trading days.
Peraso announces 1-for-40 reverse stock split effective Jan 2; shares reduce from 30.7M to 767K
Reverse 1-for-40 split effective 4:01pm ET Jan 2; trading Jan 3 on Nasdaq under PRSO, new CUSIP 71360T200.
Peraso Q3 revenue $4.5M (+87% QoQ), net loss narrows; lays off 28% of workforce
Q3 revenue $4.5M (+87% sequential, +36% YoY); GAAP gross margin 45.4%, non-GAAP 58.0%.
On December 16, 2022, Daniel Lewis retired from his position as vice president and general manager of memory products of Peraso Inc. (the “Company”), effective immediately.
Mr. Lewis will no longer serve as the President of the Company but will now serve as Vice President, General Manager of Memory Products
the Board appointed Ronald Glibbery, as Chief Executive Officer of the Company, and Brad Lynch, as Chief Operating Officer of the Company.
Scott Lewis and Daniel J. O’Neil, resigned from the Board
Scott Lewis and Daniel J. O’Neil, resigned from the Board
the Board appointed Ronald Glibbery, as Chief Executive Officer of the Company, and Brad Lynch, as Chief Operating Officer of the Company.
Max materiality 0.85 · Median 0.65 · Most common event other_material